메뉴 건너뛰기




Volumn 11, Issue 7, 2005, Pages 2695-2701

Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIAZIRIDINYL 3 HYDROXYMETHYL 6 METHYL 1,4 BENZOQUINONE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLODEXTRIN; MITOMYCIN C; POVIDONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SODIUM CHLORIDE; UNCLASSIFIED DRUG;

EID: 17644389892     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1751     Document Type: Article
Times cited : (25)

References (56)
  • 1
    • 0023547926 scopus 로고
    • Metabolism and reactions of quinoid anticancer agents
    • Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther 1987;35:57-162.
    • (1987) Pharmacol Ther , vol.35 , pp. 57-162
    • Powis, G.1
  • 2
    • 0034321937 scopus 로고    scopus 로고
    • Clinical applications of quinone-containing alkylating agents
    • Begleiter A. Clinical applications of quinone-containing alkylating agents. Front Biosci 2000;5:E153-71.
    • (2000) Front Biosci , vol.5
    • Begleiter, A.1
  • 4
    • 0020021086 scopus 로고
    • Hypoxic cell specific chemotherapeutic agents
    • Sartorelli AC. Hypoxic cell specific chemotherapeutic agents. Adv Enzyme Regul 1982;20:233-44.
    • (1982) Adv Enzyme Regul , vol.20 , pp. 233-244
    • Sartorelli, A.C.1
  • 5
    • 0023902264 scopus 로고
    • Therapeutic attack of hypoxic cells of solid tumours: Presidential address
    • Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumours: presidential address. Cancer Res 1988;48:775-8.
    • (1988) Cancer Res , vol.48 , pp. 775-778
    • Sartorelli, A.C.1
  • 6
    • 0028645493 scopus 로고
    • Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer drugs and quinone metabolising enzymes, particularly DT-diaphorase
    • Workman P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer drugs and quinone metabolising enzymes, particularly DT-diaphorase. Oncol Res 1994;6:461-75.
    • (1994) Oncol Res , vol.6 , pp. 461-475
    • Workman, P.1
  • 7
    • 0032053823 scopus 로고    scopus 로고
    • The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
    • Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-16.
    • (1998) Cancer Res , vol.58 , pp. 1408-1416
    • Brown, J.M.1    Giaccia, A.J.2
  • 8
    • 0027429970 scopus 로고
    • Reductive activation of mitomycin C by NADH:cytochrome b5 reductase
    • Hodnick WF, Sartorelli AC. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase. Cancer Res 1993;53:4907-12.
    • (1993) Cancer Res , vol.53 , pp. 4907-4912
    • Hodnick, W.F.1    Sartorelli, A.C.2
  • 9
    • 0032502684 scopus 로고    scopus 로고
    • The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells
    • Belcourt MF, Hodnick WF, Rockwell S, Sartorelli AC. The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells. J Biol Chem 1998;273:8875-81.
    • (1998) J Biol Chem , vol.273 , pp. 8875-8881
    • Belcourt, M.F.1    Hodnick, W.F.2    Rockwell, S.3    Sartorelli, A.C.4
  • 10
    • 0021345793 scopus 로고
    • Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase
    • Pan SS, Andrews PA, Glover CJ, Bachur NR. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 1984;259:959-66.
    • (1984) J Biol Chem , vol.259 , pp. 959-966
    • Pan, S.S.1    Andrews, P.A.2    Glover, C.J.3    Bachur, N.R.4
  • 11
    • 0025673868 scopus 로고
    • Activation of mitomycin C by NADPH:cytochrome P-450 reductase
    • Bligh HF, Bartoszek A, Robson CN, et al. Activation of mitomycin C by NADPH:cytochrome P-450 reductase. Cancer Res 1990;50:7789-92.
    • (1990) Cancer Res , vol.50 , pp. 7789-7792
    • Bligh, H.F.1    Bartoszek, A.2    Robson, C.N.3
  • 12
    • 0025688249 scopus 로고
    • Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells
    • Siegel D, Gibson NW, Preusch PC, Ross D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 1990;50:7483-9.
    • (1990) Cancer Res , vol.50 , pp. 7483-7489
    • Siegel, D.1    Gibson, N.W.2    Preusch, P.C.3    Ross, D.4
  • 13
    • 0025893246 scopus 로고
    • The role of NAD(P)H: Quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9
    • Walton MI, Smith PJ, Workman P. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun 1991;3:199-206.
    • (1991) Cancer Commun , vol.3 , pp. 199-206
    • Walton, M.I.1    Smith, P.J.2    Workman, P.3
  • 14
    • 0027048768 scopus 로고
    • Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity
    • Gibson NW, Hartley JA, Butler J, Siegel D, Ross D. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol 1992;42:531-6.
    • (1992) Mol Pharmacol , vol.42 , pp. 531-536
    • Gibson, N.W.1    Hartley, J.A.2    Butler, J.3    Siegel, D.4    Ross, D.5
  • 15
    • 0025917452 scopus 로고
    • High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin
    • Cresteil T, Jaiswal AK. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 1991;42:1021-7.
    • (1991) Biochem Pharmacol , vol.42 , pp. 1021-1027
    • Cresteil, T.1    Jaiswal, A.K.2
  • 16
    • 0026700546 scopus 로고
    • Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C
    • Malkinson AM, Siegel D, Forrest GL, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res 1992;52:4752-7.
    • (1992) Cancer Res , vol.52 , pp. 4752-4757
    • Malkinson, A.M.1    Siegel, D.2    Forrest, G.L.3
  • 17
    • 0027268350 scopus 로고
    • NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues
    • Belinsky M, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 1993;12:103-17.
    • (1993) Cancer Metastasis Rev , vol.12 , pp. 103-117
    • Belinsky, M.1    Jaiswal, A.K.2
  • 18
    • 0028783332 scopus 로고
    • DT-diaphorase activity in normal and neoplastic human tissues: An indicator for sensitivity to bioreductive agents?
    • Smitskamp-Wilms E, Giaccone G, Pinedo HM, van der Laan BF, Peters GJ. DT-diaphorase activity in normal and neoplastic human tissues: an indicator for sensitivity to bioreductive agents? Br J Cancer 1995;72:917-21.
    • (1995) Br J Cancer , vol.72 , pp. 917-921
    • Smitskamp-Wilms, E.1    Giaccone, G.2    Pinedo, H.M.3    Van Der Laan, B.F.4    Peters, G.J.5
  • 20
    • 0031672124 scopus 로고    scopus 로고
    • Enzymology of mitomycin C metabolic activation in tumour tissue: Implications for enzyme-directed bioreductive drug development
    • Cummings J, Spanswick VJ, Tomasz M, Smyth JF. Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol 1998;56:405-14.
    • (1998) Biochem Pharmacol , vol.56 , pp. 405-414
    • Cummings, J.1    Spanswick, V.J.2    Tomasz, M.3    Smyth, J.F.4
  • 21
    • 0033801337 scopus 로고    scopus 로고
    • Immunodetection of NAD(P)H: Quinone oxidoreductase 1 (NQO1) in human tissues
    • Siegel D, Ross D. Immunodetection of NAD(P)H: quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 2000;29:246-53.
    • (2000) Free Radic Biol Med , vol.29 , pp. 246-253
    • Siegel, D.1    Ross, D.2
  • 22
    • 0034877061 scopus 로고    scopus 로고
    • Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system
    • Zappa F, Ward T, Butler J, Pedrinis E, McGown A. Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system. J Histochem Cytochem 2001;49:1187-8.
    • (2001) J Histochem Cytochem , vol.49 , pp. 1187-1188
    • Zappa, F.1    Ward, T.2    Butler, J.3    Pedrinis, E.4    McGown, A.5
  • 24
    • 0024328012 scopus 로고
    • Increased sensitivity of quinone resistant cells to mitomycin C
    • Begleiter A, Robotham E, Lacey G, Leith MK. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett 1989;45:173-6.
    • (1989) Cancer Lett , vol.45 , pp. 173-176
    • Begleiter, A.1    Robotham, E.2    Lacey, G.3    Leith, M.K.4
  • 25
    • 0026475156 scopus 로고
    • The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells
    • Pan SS, Akman SA, Forrest GL, Hipsher C, Johnson R. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells. Cancer Chemother Pharmacol 1992;31:23-31.
    • (1992) Cancer Chemother Pharmacol , vol.31 , pp. 23-31
    • Pan, S.S.1    Akman, S.A.2    Forrest, G.L.3    Hipsher, C.4    Johnson, R.5
  • 26
    • 0026505943 scopus 로고
    • NAD (P) H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
    • Traver RD, Horikoshi T, Danenberg KD, et al. NAD (P) H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992;52:797-802.
    • (1992) Cancer Res , vol.52 , pp. 797-802
    • Traver, R.D.1    Horikoshi, T.2    Danenberg, K.D.3
  • 27
    • 0029917028 scopus 로고    scopus 로고
    • Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9
    • Fitzsimmons SA, Workman P, Grever M, et al. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 1996;88:259-69.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 259-269
    • Fitzsimmons, S.A.1    Workman, P.2    Grever, M.3
  • 28
    • 0029929226 scopus 로고    scopus 로고
    • DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric cancer cell lines
    • Mikami K, Naito M, Tomida A, et al. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric cancer cell lines. Cancer Res 1996;56:2823-6.
    • (1996) Cancer Res , vol.56 , pp. 2823-2826
    • Mikami, K.1    Naito, M.2    Tomida, A.3
  • 29
    • 0033709414 scopus 로고    scopus 로고
    • Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: Implications for enzyme-directed bioreductive drug development
    • Phillips RM, Burger AM, Loadman PM, et al. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development. Cancer Res 2000;60:6384-90.
    • (2000) Cancer Res , vol.60 , pp. 6384-6390
    • Phillips, R.M.1    Burger, A.M.2    Loadman, P.M.3
  • 30
    • 0033853035 scopus 로고    scopus 로고
    • The role of reductive enzymes in the cancer cell resistance to mitomycin C
    • Cummings J. The role of reductive enzymes in the cancer cell resistance to mitomycin C. Drug Resist Updat 2000;3:143-8.
    • (2000) Drug Resist Updat , vol.3 , pp. 143-148
    • Cummings, J.1
  • 31
    • 0035877252 scopus 로고    scopus 로고
    • Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones
    • Winski SL, Swann E, Hargreaves RH, et al. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 2001;61:1509-16.
    • (2001) Biochem Pharmacol , vol.61 , pp. 1509-1516
    • Winski, S.L.1    Swann, E.2    Hargreaves, R.H.3
  • 32
    • 12144287215 scopus 로고    scopus 로고
    • Immunohistochemical analysis of NAD(P)H: Quinone oxidoreductase and NADPH cvtochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy
    • Basu S, Brown JE, Flannigan GM, et al. Immunohistochemical analysis of NAD(P)H : quinone oxidoreductase and NADPH cvtochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy. Int J Cancer 2004;109:703-9.
    • (2004) Int J Cancer , vol.109 , pp. 703-709
    • Basu, S.1    Brown, J.E.2    Flannigan, G.M.3
  • 33
    • 0028097816 scopus 로고
    • Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity
    • Plumb JA, Workman P. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity. Int J Cancer 1994;56:134-9.
    • (1994) Int J Cancer , vol.56 , pp. 134-139
    • Plumb, J.A.1    Workman, P.2
  • 34
    • 0028063368 scopus 로고
    • DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9
    • Plumb JA, Gerritsen M, Workman P. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9. Br J Cancer 1994;70:1136-43.
    • (1994) Br J Cancer , vol.70 , pp. 1136-1143
    • Plumb, J.A.1    Gerritsen, M.2    Workman, P.3
  • 35
    • 0029121481 scopus 로고
    • Nicotinamide adenine dinucleotide (phosphate): Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines
    • Beall HD, Murphy AM, Siegel D, et al. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol Pharmacol 1995;48:499-504.
    • (1995) Mol Pharmacol , vol.48 , pp. 499-504
    • Beall, H.D.1    Murphy, A.M.2    Siegel, D.3
  • 36
    • 0032435478 scopus 로고    scopus 로고
    • A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent
    • Winski SL, Hargreaves RH, Butler J, Ross D. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin Cancer Res 1998;4:3083-8.
    • (1998) Clin Cancer Res , vol.4 , pp. 3083-3088
    • Winski, S.L.1    Hargreaves, R.H.2    Butler, J.3    Ross, D.4
  • 37
    • 0027159001 scopus 로고
    • Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase
    • Berardini MD, Souhami RL, Lee CS, et al. Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase. Biochemistry 1993;32:3306-12.
    • (1993) Biochemistry , vol.32 , pp. 3306-3312
    • Berardini, M.D.1    Souhami, R.L.2    Lee, C.S.3
  • 38
    • 0034609585 scopus 로고    scopus 로고
    • Sigmatropic reactions of the aziridinyl semiquinone species. Why aziridinyl benzoquinones are metabolically more stable than aziridinyl indoloquinones
    • Xing C, Skibo EB. Sigmatropic reactions of the aziridinyl semiquinone species. Why aziridinyl benzoquinones are metabolically more stable than aziridinyl indoloquinones. Biochemistry 2000;39:10770-80.
    • (2000) Biochemistry , vol.39 , pp. 10770-10780
    • Xing, C.1    Skibo, E.B.2
  • 39
    • 0033785989 scopus 로고    scopus 로고
    • Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo
    • Sharp SY, Kelland LR, Valenti MR, et al. Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo. Mol Pharmacol 2000;58:1146-55.
    • (2000) Mol Pharmacol , vol.58 , pp. 1146-1155
    • Sharp, S.Y.1    Kelland, L.R.2    Valenti, M.R.3
  • 40
    • 0344442219 scopus 로고    scopus 로고
    • Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts
    • In Press
    • Cummings J, Langdon S, Butler J, Ward TH, Smyth JF. Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts. Anticancer Res. In Press 2003.
    • (2003) Anticancer Res
    • Cummings, J.1    Langdon, S.2    Butler, J.3    Ward, T.H.4    Smyth, J.F.5
  • 41
    • 2442484645 scopus 로고    scopus 로고
    • Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: Evaluation of the activity of RH1
    • Dehn DL, Winski SL, Ross D. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1. Clin Cancer Res 2004;10:3147-55.
    • (2004) Clin Cancer Res , vol.10 , pp. 3147-3155
    • Dehn, D.L.1    Winski, S.L.2    Ross, D.3
  • 42
    • 0033981669 scopus 로고    scopus 로고
    • Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice
    • Loadman PM, Phillips RM, Lim LE, Bibby MC. Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl- 1,4-benzoquinone), in mice. Biochem Pharmacol 2000;59:831-7.
    • (2000) Biochem Pharmacol , vol.59 , pp. 831-837
    • Loadman, P.M.1    Phillips, R.M.2    Lim, L.E.3    Bibby, M.C.4
  • 43
    • 21944447905 scopus 로고    scopus 로고
    • Chemosensitivity, DNA cross linking and enzyme profiling in ovarian tumuor cells derived from patients
    • Ward TH, Richards JT, McGown AT, Butler J. Chemosensitivity, DNA cross linking and enzyme profiling in ovarian tumuor cells derived from patients. Neoplasma 1999;46:52-60.
    • (1999) Neoplasma , vol.46 , pp. 52-60
    • Ward, T.H.1    Richards, J.T.2    McGown, A.T.3    Butler, J.4
  • 44
    • 0029131331 scopus 로고
    • Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones
    • Ward TH, Haran MS, Whittaker D, et al. Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones. Biochem Pharmacol 1995;50:459-64.
    • (1995) Biochem Pharmacol , vol.50 , pp. 459-464
    • Ward, T.H.1    Haran, M.S.2    Whittaker, D.3
  • 45
    • 0030920810 scopus 로고    scopus 로고
    • Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells
    • Ward TH, Butler J, Shahbakhti H, Richards JT. Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells. Biochem Pharmacol 1997;53:1115-21.
    • (1997) Biochem Pharmacol , vol.53 , pp. 1115-1121
    • Ward, T.H.1    Butler, J.2    Shahbakhti, H.3    Richards, J.T.4
  • 47
    • 16744368637 scopus 로고    scopus 로고
    • United Kingdom Co-ordinating Comittee on Cancer Research (UKCCR) guidelines for the welfare of animals in experimental neoplasia
    • Workman P, Twentyman P, Balkwill F, et al. United Kingdom Co-ordinating Comittee on Cancer Research (UKCCR) guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 1998;77:1-10.
    • (1998) Br J Cancer , vol.77 , pp. 1-10
    • Workman, P.1    Twentyman, P.2    Balkwill, F.3
  • 49
    • 1942503333 scopus 로고    scopus 로고
    • Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation
    • Kim JY, West CM, Valentine H, et al. Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation. Radiother Oncol 2004;70:311-7.
    • (2004) Radiother Oncol , vol.70 , pp. 311-317
    • Kim, J.Y.1    West, C.M.2    Valentine, H.3
  • 50
    • 0035097762 scopus 로고    scopus 로고
    • Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone
    • Cheung AP, Struble E, Nguyen N, Liu P. Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone. J Pharm Biomed Anal 2001;24:957-66.
    • (2001) J Pharm Biomed Anal , vol.24 , pp. 957-966
    • Cheung, A.P.1    Struble, E.2    Nguyen, N.3    Liu, P.4
  • 51
    • 0036660428 scopus 로고    scopus 로고
    • Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma
    • Spanswick VJ, Craddock C, Sekhar M, et al. Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood 2002;100:224-9.
    • (2002) Blood , vol.100 , pp. 224-229
    • Spanswick, V.J.1    Craddock, C.2    Sekhar, M.3
  • 52
    • 0034643405 scopus 로고    scopus 로고
    • The alkaline single cell electrophoresis assay with eight mouse organs: Results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers
    • Tsuda S, Matsusaka N, Madarame H, et al. The alkaline single cell electrophoresis assay with eight mouse organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers. Mutat Res 2000;467:83-98.
    • (2000) Mutat Res , vol.467 , pp. 83-98
    • Tsuda, S.1    Matsusaka, N.2    Madarame, H.3
  • 53
    • 0034661614 scopus 로고    scopus 로고
    • Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy
    • Link KH, Kornmann M, Butzer U, et al. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy. Cancer 2000;89:288-96.
    • (2000) Cancer , vol.89 , pp. 288-296
    • Link, K.H.1    Kornmann, M.2    Butzer, U.3
  • 54
    • 0034109492 scopus 로고    scopus 로고
    • Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer
    • Konecny G, Crohns C, Pegram M, et al. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol 2000;77:258-63.
    • (2000) Gynecol Oncol , vol.77 , pp. 258-263
    • Konecny, G.1    Crohns, C.2    Pegram, M.3
  • 55
    • 0033367019 scopus 로고    scopus 로고
    • Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs
    • Kurihara N, Kubota T, Furukawa T, et al. Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. Anticancer Res 1999;19:5155-8.
    • (1999) Anticancer Res , vol.19 , pp. 5155-5158
    • Kurihara, N.1    Kubota, T.2    Furukawa, T.3
  • 56
    • 4644273680 scopus 로고    scopus 로고
    • Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action
    • Suggitt M, Fearnley J, Swaine DJ, et al. Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action. Teratog Carcinog Mutagen 2003;Suppl 2:13-29.
    • (2003) Teratog Carcinog Mutagen , Issue.2 SUPPL. , pp. 13-29
    • Suggitt, M.1    Fearnley, J.2    Swaine, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.